Embolx

Sunnyvale, CA · Founded 2013 · Privately Held (backing)

Developer of medical devices designed for arterial embolization procedures. Embolx is based in Sunnyvale, CA and was founded in 2013. Its last reported valuation was $37.6 million in Jul 2021. It has raised $16.5 million across 3 recorded rounds; the latest was a $1.6 million seed round in Oct 2022.

Last reported valuation
$37.6M
Oct 2026
Priced at
—
Total raised
$16.5M
Last round
Seed Round
Oct 2022
What is Embolx worth?
$37.6Mlast reported valuation · Oct 2026

Embolx's last reported valuation, Jul 2021. Nothing priced has surfaced since.

Free account
More of Embolx with a free account
  • ·The complete investor list: 14 names
  • ·Watch Embolx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Embolx funding history

3 rounds
DateRoundRaisedPost-money
Oct 2022Seed Round$1.6M▮
May 2014Seed Round$250K▮
Feb 2014Seed Round$250K▮
Unlock post-money valuations

Membership and data by Private Market View

Embolx valuation

Embolx's last reported valuation was $37.6 million in Jul 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has Embolx raised?

Embolx has raised $16.5 million in total; 3 of its rounds are on record, from 2014 on. The largest on record was a $250,000 seed round in Feb 2014; the most recent was a $1.6 million seed round in Oct 2022.

Embolx has filed 5 Form Ds with the SEC since 2014, most recently in Nov 2022 ($1.6 million sold to 5 investors).

How Embolx's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Embolx, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Embolx

What is Embolx worth?
Embolx is valued at $37.6M as of Oct 2026. Embolx's last reported valuation, Jul 2021. Nothing priced has surfaced since.
How much has Embolx raised?
Embolx has raised $16.5M in total funding across 3 recorded rounds.
When did Embolx last raise?
Embolx last raised in Oct 2022 (Seed Round), raising $1.6M.